VitalCaring has announced the results of a seven-month AI-driven cognitive care pilot program. The program provided personalized therapy to patients with cognitive disorders using Constant Therapy’s digital speech, language and cognitive therapy platform as part of its home-based services for selected patients. Based in Dallas, VitalCaring provides home health and hospice care to patients in […]
VitalCaring
It’s the interest rate, stupid. Home health, home care and hospice industry voices – including myself – have regularly pointed toward internal factors affecting M&A over the last two and a half years. In the end, the overarching, main headwind was always the extremely high interest rates that were put forth by the Federal Reserve […]
Amedisys Inc. (Nasdaq: AMED) is waiting for multiple big-time transactions to come to fruition by year end. In the meantime, it continues to grow its non-Medicare revenue and its high-acuity care business considerably. The company released its second-quarter earnings on Wednesday, without an accompanying call. It has not held an official earnings call since UnitedHealth […]
On late Friday, Amedisys Inc. (Nasdaq: AMED) announced that it had agreed to divest certain locations to VitalCaring, in a deal that would be a massive one for the home health industry. It could clear the way for UnitedHealth Group (NYSE: UNH) to finalize its takeover of Amedisys, and also turn VitalCaring into one of […]
Amedisys Inc. (Nasdaq: AMED) filed paperwork Friday with the U.S. Securities and Exchange Commission saying it has agreed to divest “certain” locations to an affiliate of home health and hospice company VitalCaring. The divestiture was a way for Amedisys to avoid further antitrust concerns from regulators prior to it joining UnitedHealth Group (NYSE: UNH). UnitedHealth […]
The Centers for Medicare & Medicaid Services’ (CMS) proposed home health payment rule, released Wednesday, included significant cuts for the third straight year. Those cuts, among other proposed changes, raise questions over the stability of the industry in the coming years. It has providers asking themselves and others the question: “Why us?” For an industry […]
As UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) work on a divestment strategy that will satisfy regulators, a lot hangs in the balance. For one, UnitedHealth Group and Optum’s deal for the home health and hospice provider Amedisys is one of the largest deals in the industry’s history, only trailing Optum’s deal for Amedisys’ […]
In early May, it was reported that UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) were working on a divestment package to satisfy regulator concerns over antitrust violations. Capitol Forum had previously reported that Amedisys was aiming to offload more than 100 of its locations to a “private equity-backed buyer.” On Friday, Capitol Forum reported […]
The Medicaid Access Rule has been finalized, with six years until the implementation of the 80-20 provision. There’s no time to rest for home-based care providers and advocates on the regulation front, however. Summer is near, and that means so is the home health proposed payment rule from the Centers for Medicare & Medicaid Services […]
Internal and external headwinds have conjoined to curtail dealmaking in home-based care over the last couple of years. Amid those headwinds, however, there are companies like New Day Healthcare and VitalCaring that are banking on big-time growth in 2024 and 2025, largely driven by acquisition. As growing providers, each company has picked up what they […]
Subscribe
Receive industry updates and breaking news from HHCN